Generic drug approved by FDA (through July 2009): melphalan injection
Melphalan injection, eq 50 mg base/vial (equiv to Alkeran injection)
SYNERX
Drugs to Watch: Mental Health Conditions
April 11th 2024The FDA is reviewing two novel therapies: a psychedelic-assisted therapy for PTSD with a target action date of Aug. 11, 2024, and therapy for schizophrenia that does not directly block dopamine receptors with an action date of Sept. 26, 2024.